Halozyme Therapeutics reported a GAAP net profit of $335.94 million for 9M 2021, up 6 times from $55.921 million in the previous year. Revenues increased 2.3 times to $341.307 million from $145.891 million a year earlier.
Halozyme Therapeutics reported a GAAP net profit of $335.94 million for 9M 2021, up 6 times from $55.921 million in the previous year. Revenues increased 2.3 times to $341.307 million from $145.891 million a year earlier. 
ir.halozyme.com
English (US) 